I am recommending the purchase of United Healthcare June 16, 2017 165 Call (UNH_170616100C16500) up to $5. United is the largest health insurer in the U.S. The stock has fallen in sympathy with Molina Healthcare (NYSE: MOH) as the latter missed its Q$ earnings and announced that it is likely… Read More

Dr. Joe Duarte has been a professional investor and independent analyst since 1990. He has appeared on CNBC, has published articles on Marketwatch.com and has been widely quoted in the major media including The Wall Street Journal and Barron’s magazine. He is author of “Trading Options for Dummies,” 2nd Edition and “Trading Futures for Dummies.” His second book was “Successful Biotech Investing.”
Analyst Articles
Now a value stock, this big pharma is managing its current drugs and its pipeline to perfection. Read More
Sell the Bristol Myers March $50 Call for a 25% three-week profit Read More
I am issuing a buy recommendation for Teradyne (NYSE: TER), a leader in electronic manufacturing equipment testing equipment. Read More
Shares of AMAG Pharmaceuticals (NSDQ: AMAG), a pharmaceutical company focusing on maternal medicine, fell below our Sell Stop of $22 and are now rated SELL. The company’s shares tumbled after it announced positive top line results from its Definitive Pharmacokinetic Study for Makena Subcutaneous Administration and will file a New… Read More
I am issuing a buy Recommendation on Synergy Pharmaceuticals (NSDQ: SGYP), a biotech company focusing in diseases and conditions of the digestive system. Read More
I am recommending the purchase of the Bristol Myers March 17, 2017 Call Option with a $50 strike price. Read More
Bio Telemetry transforms cardiac care with a patient’s cellphone. Read More
The stock market is in a bit of a pickle, as is maybe the entire world. Read More
It’s time to take profits on Rollins Inc., a stock that seems to be stalling out, and also to clear out the options hanger in order to make room for more opportunities. Rollins . (NYSE: ROL), the global leader in pest control, has exterminated the profit blues for us since we… Read More